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Studies focusing on antibiotic prescribing indicate that 
approximately one-third of hospitalized infants and 
children receive antibiotics, often on an empirical basis 
[ 1-31. Alniost half of all antibiotic prescriptions have 
been found to be inappropriate, based on clinical and 
economic criteria [4]. In addition, serious consequences 
in terms of mortality and complications can result from 
inappropriate antibiotic therapy [ 5 ] .  Because of the 
rising costs in health care, lack of uniformity in pre- 
scribing attitudes and the emergence of antibiotic 
resistance, monitoring and controlling antibiotic use is 
of growing concern. Several professional societies have 
issued urgent statements advocating reduction of the 
use of antibiotics worldwide by means of strict local 
antibiotic policies. In order to implement such a policy, 
it is important to determine on a local and global level 
the presence or absence of uniformity in antibiotic- 
prescribing attitudes for in- and outpatients. 
In order to study the degree of uniformity of 
empirical antibiotic therapy in pediatrics, question- 
naires with clinical cases were sent to all 156 pedia- 
tricians and pediatric residents in the northern part 
of The Netherlands and to 100 randomly selected 
pediatricians in Belgium. In The Netherlands, 67 were 
working in one university hospital, and 89 were divided 
among 25 regional hospitals. Initial non-responders 
received up to two additional mailings of the same 
questionnaire. The questionnaire contained 13 clear 
clinical situations (Table 1). For each of these cases, an 
empirical antibiotic treatment was requested, including 
generic name of the drugs, dose and duration of 
treatment. Data were analyzed for all Dutch pediatri- 
cians (in the university setting and the regional setting) 
and Belgian pediatricians separately. The survey was 
conducted anonymously. 
In The Netherlands, 30 pediatricians (71%) and 30 
pediatric residents (80%) of the university hospital and 
62 pediatricians (69.7%) of the community hospitals 
returned questionnaires, of which 107 (68.6%) were 
completed and five (3%) were returned without any 
answers. In Belgium, 38 pediatricians (38%) returned 
questionnaires, of which 36 (36%) were completed and 
2 (3%) were returned without any answers. A wide- 
spread variability in choice of antibiotic therapy was 
found for each case even in the generic class of the 
antibiotic. Looking at the different generic drugs even 
less uniformity in choice could be found (data not 
Table 1 Number of antibiotic classes chosen for each case with, in parentheses, the number of respondents for the particular 
case. The following antibiotic classes were defined: penicillins, cephalosporins, aminoglycosides, sulfonamides, vancomycin, 
quinolones, metronidazole and all different combinations of these individual classes 
Pediatricians 
and residents, 
The Netherlands 
Pediatricians, 
Belgium 
Case number and description (n=112) (n=36) 
1. A 3-week-old child with bacterial meningitis 
2. A 4-year-old girl with clinically and radiologically proven 
5 (104) 6 (34) 
bacterial pneumonia 4 (106) 4 (36) 
3. A 7-year-old boy with sinusitis 4 (103) 3 (36) 
4. A 5-year-old girl with pyelonephritis 8 (101) 7 (36) 
6. A premature infant, with respiratory distress and sepsis 6 (33) 
and bloody diarrhea 15 (99) 10 (34) 
9. An 8-year-old girl with atypical pneumonia 5 (99) 5 (36) 
10. A 3-year-old girl with bacterial meningitis 9 (105) 5 (35) 
11. A 4-year-old girl with endocarditis 8 (68) 7 (25) 
12. A 2-year-old girl with infected eczema 7 (96) 5 (36) 
13. A 9-year-old boy with septic arthritis 4 (88) 4 (31) 
5. A 4-year-old child with bilateral otitis media 
7. A 12-year-old girl with high fever, hypotension, tachycardia 
8. An 8-year-old boy with osteomyelitis of the ankle 
3 (106) 5 (36) 
7 (104) 
6 (99) 5 (36) 
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shown). The greatest variability was found for central 
nervous system infections or endocarditis for the Dutch 
and cases with suspicion of bacteremia or endocar&tis 
for the Belgian pediatricians. Both groups of pedia- 
tricians showed least variability for cases with lower 
respiratory tract infections and otitis media. In addition, 
the dosage of the chosen therapy showed a considerable 
variability and did not always comply with the literature 
or commonly used formularies. For both the Dutch 
and Belgian pediatricians, greatest variability was found 
in the dosage of penicillin for central nervous system 
infections in a range between 13-500 mg/kg and 25- 
300 mg/kg respectively. Only 26% of the amoxicillin 
prescriptions were within the accepted range in dosage 
(200-400 mg/kg) as described in various textbooks of 
pediatrics. In the Netherlands, a child with suspicion of 
respiratory tract infection was treated intravenously or 
orally with a dosage of penicillin between 50 and 200 
mg/kg and 10 and 100 mg/kg, respectively. More than 
75% were treated with a dosage as suggested in text- 
books of pediatrics. For the Belgian pehatricians, the 
results were comparable. The dosage of the amino- 
glycosides netilmicin, gentamicin and tobramycin was 
too low or too high in 33% and 10% of prescriptions 
in the Netherlands and Flanders, respectively. For 
central nervous system infections, 60% and 70% of all 
children were treated with a dosage of ceftriaxone 
according to the advised regimen in literature. The 
others were treated with a low dosage. For cefiazidime 
and cefotaxime 90% and 52%. respectively, were treated 
with correct dosages. Finally, the suggested duration of 
therapy showed a remarkable variability for both groups. 
Again, generally accepted guidelines were breached on 
several occasions. 
In conclusion, considerable variability was found 
in empirical antibiotic selection among pediatricians 
and pediatric residents in the Netherlands and Belgium. 
This variability was evident for selected antibiotics as 
well as for dose and duration of therapy. The data were 
derived from written case simulations, which are not 
always predictive of physicians' actual behavior; how- 
ever, the cases were clear, straightforward and common. 
In order to optimize patient care, to achieve a reduction 
in healthcare costs and to reduce the emergence of drug 
resistance, antibiotics should be used rationally. There- 
fore, an urgent need for more appropriate selection and 
use of antibiotics exists [6,7]. 
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